To determine whether the ACAP4 protein is essential for IL6-induced hepatoma cell migration, we knocked out ACAP4 in MHCC97H and HepG2 cells (ACAP4KO) via CRISPR-mediated technology (Figure S4E-4F). Here, IL6 is linked to hepatocellular carcinoma.